Insider Shareholders with Direct Ownership of Palisade Bio, Inc. (PALI)
This section provides a comprehensive overview of the insiders with direct ownership of Palisade Bio, Inc. (PALI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
PALISADE BIO, INC. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Thomas Hallam
Chief Executive Officer |
57,592 | 0 | 57,592 $150,315 | 4 |
Aug 16, 2022
Added 40.99%
|
Michael John Dawson
Chief Medical Officer |
15,000 | 0 | 15,000 $39,150 | 1 |
Mar 29, 2022
Added 50.0%
|
John David Finley
CEO, CFO, Director |
256,882 | 7,264 | 13,472 $35,161 | 34 |
May 28, 2024
Reduced 4.31%
|
Cristina Csimma
Director |
12,800 | 0 | 12,862 $33,569 | 1 |
Feb 08, 2024
Added 31.15%
|
Stephanie Diaz
Director |
12,800 | 0 | 12,800 $33,408 | 1 |
Feb 08, 2024
Added 31.26%
|
James R Neal
Director |
10,920 | 0 | 10,920 $28,501 | 1 |
Feb 09, 2024
Added 34.77%
|
Robert J. Trenschel
Director |
25,919 | 300 | 10,920 $28,501 | 7 |
Feb 08, 2024
Added 34.77%
|
Mitchell Lawrence Jones
Chief Medical Officer |
16,197 | 5,191 | 3,852 $10,053 | 8 |
May 28, 2024
Reduced 10.69%
|
Robert Curtis Mc Rae
Chief Operating Officer |
655 | 270 | 625 $1,631 | 2 |
Apr 03, 2023
Reduced 30.17%
|
Binxian Wei
Director |
465 | 0 | 467 $1,218 | 1 |
Jun 11, 2024
Added 49.89%
|
Donald Allen Williams
Director |
1,340 | 0 | 340 $887 | 2 |
Jun 11, 2024
Added 50.0%
|